CNP
36
-8
AKAM
51
-2
UA
36
-5
NUE
50
2
EQR
37
-5
WMB
63
-3
RL
66
-2
AIZ
47
-2
CVX
26
6
CFG
54
-4
ADP
61
-3
DUK
37
-3
DOV
57
-2
CAT
57
2
ALL
35
-3
PRU
51
-3
ABT
62
9
IVZ
52
6
ED
37
-2
NOV
49
-3
CNP
36
-8
AKAM
51
-2
UA
36
-5
NUE
50
2
EQR
37
-5
WMB
63
-3
RL
66
-2
AIZ
47
-2
CVX
26
6
CFG
54
-4
ADP
61
-3
DUK
37
-3
DOV
57
-2
CAT
57
2
ALL
35
-3
PRU
51
-3
ABT
62
9
IVZ
52
6
ED
37
-2
NOV
49
-3
Financhill
Back

BeiGene Vs. Theravance Biopharma Industry Stock Comparison

Sell
35

BGNE
BeiGene

Last Price:
207.51
Seasonality Move:
13.54%
Sell
48

TBPH
Theravance Biopharma

Last Price:
8.23
Seasonality Move:
11.3%
Sell
35
BeiGene (BGNE) is a Sell

Is BeiGene a Buy, Sell or Hold?

  • The current BeiGene [BGNE] share price is $204.21. The Score for BGNE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • BGNE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Theravance Biopharma (TBPH) is a Sell

Is Theravance Biopharma a Buy, Sell or Hold?

  • The current Theravance Biopharma [TBPH] share price is $8.28. The Score for TBPH is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • TBPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BGNE Stock Price Chart

What is BeiGene's stock price today?

  • The BeiGene share price today is $204.21
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BGNE is experiencing selling pressure, which indicates risk of future bearish movement.

TBPH Stock Price Chart

What is Theravance Biopharma's stock price today?

  • The Theravance Biopharma share price today is $8.28
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TBPH is experiencing selling pressure, which indicates risk of future bearish movement.

BGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.07 Sell
Relative Strength Index (14 RSI): 39.19 Sell
Chaikin Money Flow: -140998 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (212.53 - 236.09) Sell
Bollinger Bands (100): (158.06 - 216.04) Buy

TBPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.06 Buy
Relative Strength Index (14 RSI): 45.74 Sell
Chaikin Money Flow: -78719 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.09 - 8.65) Sell
Bollinger Bands (100): (7.91 - 9.27) Sell

BGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 211.82 Sell
20-day SMA: 223.29 Sell
50-day SMA: 211.3 Sell
200-day SMA: 171.46 Buy
8-day EMA: 210.89 Sell
20-day EMA: 216.1 Sell
50-day EMA: 209.26 Sell
200-day EMA: 185.44 Buy

TBPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.53 Sell
20-day SMA: 8.43 Sell
50-day SMA: 8.24 Buy
200-day SMA: 8.83 Sell
8-day EMA: 8.46 Sell
20-day EMA: 8.44 Sell
50-day EMA: 8.41 Sell
200-day EMA: 8.87 Sell

BeiGene Earnings Growth & BGNE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.08 per share, and an increase next year of $4.67 per share.

Theravance Biopharma Earnings Growth & TBPH Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.32 per share, and an increase next year of $1.09 per share.

BeiGene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Theravance Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):